2 Patents
- US120644372024Methods for Treating Systemic Lupus Erythematosus and the Use of Biomarkers as a Predictor of Clinical Sensitivity to Therapies
CELGENE CORPORATION
0 cites - US1166030220233-(4-((4-(morpholinomethyl-benzyl)oxy)-1 -oxoisoindolin-2-yl)piperidine-2,6-dione for the Treatment of Systemic Lupus Erythematosus
Celgene Corporation
0 cites